Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Laura Benítez-Gutiérrez, Pablo Barreiro, Pablo Labarga, Carmen de Mendoza, José V. Fernandez-Montero, Ana Arias, José M. Peña & Vicente Soriano. (2016) Prevention and management of treatment failure to new oral hepatitis C drugs. Expert Opinion on Pharmacotherapy 17:9, pages 1215-1223.
Read now
Read now
Vincent Soriano, Pablo Labarga, Carmen de Mendoza, José V Fernández-Montero, Isabella Esposito, Laura Benítez-Gutiérrez, José M Peña & Pablo Barreiro. (2016) New hepatitis C therapies for special patient populations. Expert Opinion on Pharmacotherapy 17:2, pages 217-229.
Read now
Read now
Articles from other publishers (15)
Songtao Huang & Yanrui Ding. (2023) Predicting Binding Affinity Between MHC-I Receptor and Peptides
Based on Molecular Docking and Protein-peptide Interaction Interface
Characteristics. Letters in Drug Design & Discovery 20:12, pages 1982-1993.
Crossref
Crossref
Jian-Xin Tang, Kang-Jun Zhang, Tai-Shi Fang, Rui-Hui Weng, Zi-Ming Liang, Xu Yan, Xin Jin, Lin-Jie Xie, Xin-Chen Zeng & Dong Zhao. (2023) Outcomes of ABO-incompatible liver transplantation in end-stage liver disease patients co-infected with hepatitis B and human immunodeficiency virus. World Journal of Gastroenterology 29:11, pages 1745-1756.
Crossref
Crossref
Ayush Sharma, Prakash Kumar, Siddhartha Dutta, Rimple Jeet Kaur, Jaykaran Charan, Gaurav Chikara, Krishna Murti, Murali Kumarasamy, M. Ramesh, Krishna Pandey, V. Ravichandiran & Sameer Dhingra. (2022) Pathophysiological and Genetic Basis of Tenofovir-Induced Acute Renal Dysfunction: Strategies and Recent Developments for Better Clinical Outcomes. Current Pharmacology Reports 8:6, pages 427-438.
Crossref
Crossref
Jessica Cusato, Lucio Boglione, Amedeo De Nicolò, Gian Paolo Caviglia, Simone Mornese Pinna, Alessia Ciancio, Giulia Troshina, Antonina Smedile, Miriam Antonucci, Valeria Avataneo, Alice Palermiti, Jacopo Mula, Alessandra Manca, Giuseppe Cariti, Marco Cantù, Giorgio Maria Saracco, Giovanni Di Perri & Antonio D’Avolio. (2022) Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy. Pharmaceuticals 15:3, pages 355.
Crossref
Crossref
Pankaj Kumar Rai, Zeba Mueed, Abhiroop Chowdhury, Ravi Deval, Dinesh Kumar, Mohammad A. Kamal, Yogeshwar Singh Negi, Shubhra Pareek, Hemlata Sharma & Nitesh Kumar Poddar. (2022) Current Overviews on COVID-19 Management Strategies. Current Pharmaceutical Biotechnology 23:3, pages 361-387.
Crossref
Crossref
Virginia Solitano, Maria Corina Plaz Torres, Nicola Pugliese & Alessio Aghemo. (2021) Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?. Viruses 13:6, pages 1048.
Crossref
Crossref
A McLeod, SJ Hutchinson, S Smith, C Leen, S Clifford, A McAuley, LA Wallace, ST Barclay, P Bramley, JF Dillon, A Fraser, RN Gunson, PC Hayes, N Kennedy, E Peters, K Templeton & DJ Goldberg. (2020) Increased case‐finding and uptake of direct‐acting antiviral treatment essential for micro‐elimination of hepatitis C among people living with HIV: a national record linkage study. HIV Medicine 22:5, pages 334-345.
Crossref
Crossref
Daniel Esteban Pino Marín, Pedro Amariles, Jaime Alberto Peláez Alvárez, Gloria Priscilla Alvárez Osorio & Juliana González Ceballos. (2019) Aproximación para establecer y evaluar la relevancia clínica de las interacciones medicamentosas en el tratamiento de pacientes infectados con virus de hepatitis C, revisión estructurada (actualización 2015 – 2017). Revista Colombiana de Gastroenterología 34:2, pages 159-176.
Crossref
Crossref
Isabella Esposito, Sebastián Marciano, Leila Haddad, Omar Galdame, Alejandra Franco, Adrián Gadano, Diego Flichman & Julieta Trinks. (2018) Prevalence and Factors Related to Natural Resistance-Associated Substitutions to Direct-Acting Antivirals in Patients with Genotype 1 Hepatitis C Virus Infection. Viruses 11:1, pages 3.
Crossref
Crossref
Eva Zusinaite, Aleksandr Ianevski, Diana Niukkanen, Minna Poranen, Magnar Bjørås, Jan Afset, Tanel Tenson, Vidya Velagapudi, Andres Merits & Denis Kainov. (2018) A Systems Approach to Study Immuno- and Neuro-Modulatory Properties of Antiviral Agents. Viruses 10:8, pages 423.
Crossref
Crossref
Steven Ivulich, Glen Westall, Michael Dooley & Gregory Snell. (2018) The Evolution of Lung Transplant Immunosuppression. Drugs 78:10, pages 965-982.
Crossref
Crossref
Lucio Boglione, Amedeo De Nicolò, Simone Mornese Pinna, Jessica Cusato, Fabio Favata, Alessandra Ariaudo, Chiara Carcieri, Giuseppe Cariti, Giovanni Di Perri & Antonio D’Avolio. (2017) Role of simeprevir plasma concentrations in HCV treated patients with dermatological manifestations. Digestive and Liver Disease 49:6, pages 705-708.
Crossref
Crossref
Hui Han, Yuxin He, Jay Hu, Rhema Lau, Harrison Lee & Cheng Ji. (2017) Disrupted ER‐to‐Golgi trafficking underlies anti‐HIV drugs and alcohol‐induced cellular stress and hepatic injury. Hepatology Communications 1:2, pages 122-139.
Crossref
Crossref
Noboru Hirashima, Hiroaki Iwase, Masaaki Shimada, Nobumitsu Ryuge, Junji Imamura, Hiroki Ikeda, Yasuhito Tanaka, Nobuyuki Matsumoto, Chiaki Okuse, Fumio Itoh, Yoshiyuki Yokomaku & Tsunamasa Watanabe. (2016) Successful treatment of three patients with human immunodeficiency virus and hepatitis C virus genotype 1b co-infection by daclatasvir plus asunaprevir. Clinical Journal of Gastroenterology 10:1, pages 41-46.
Crossref
Crossref
David R. Parker, Cara M. Mangine, Brian M. Hendricks, Michael J. Cima, Stacie Mcie & Arif Sarwari. (2017) Adherence to HIV Treatment and Care at a Rural Appalachian HIV Clinic. Journal of the Association of Nurses in AIDS Care 28:1, pages 67-74.
Crossref
Crossref